To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

May 9, 2024

Register for Access to GBM 3D-Predict Testing

EBCI's Know All Your Treatment Options (KAYTO) 2024
May 17, 2024 | 11AM - 2PM PT | Free & Online

KAYTO 2024 Presenting Sponsors

Gamma Tile Official Logo - 2024
KiyateclogovBRIGHT 1920w.jpg 1
Eric Perreault 2 1 300x220 1 edited
Eric Perreault

Eric Perreault, CEO of Kiyatec, leads the biotechnology company in its mission to revolutionize cancer care by harnessing the power of functional precision medicine.

At KAYTO 2024, Eric will provide education on Kiyatec's 3D Predict™ test, which helps predict which treatment is likely to be the most effective for your specific tumor tissue, for a personalized medicine treatment approach. Register today for this free online event to learn more and get the opportunity to ask questions.

Know All Your Treatment Options (KAYTO) is a free disease education event, produced and moderated annually by the End Brain Cancer Initiative (EBCI). It is designed specifically for members of the brain tumor, brain cancer, and metastasized brain tumor community, including patients, families, and Health Care Providers.

KAYTO 2024

Register today for the opportunity to hear directly from and have direct access to specialists in this field about treatment options, clinical trials, devices, and diagnostics that you may not have heard about!

EBCI Happy cancer patient woman with hat e1665030951309

Sponsor logos

Hand holding cell phone displaying app

MORE Meetings, Events, Disease Education Education and Resources


Scan or click the QR code to download the App now!


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram